Pregnancy and reproductive risk factors for cardiovascular disease in women

AC O'Kelly, ED Michos, CL Shufelt, JV Vermunt… - Circulation …, 2022 - Am Heart Assoc
Beyond conventional risk factors for cardiovascular disease, women face an additional
burden of sex-specific risk factors. Key stages of a woman's reproductive history may …

Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association

SR El Khoudary, B Aggarwal, TM Beckie, HN Hodis… - Circulation, 2020 - Am Heart Assoc
Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …

[HTML][HTML] The clinician's guide to prevention and treatment of osteoporosis

MS LeBoff, SL Greenspan, KL Insogna… - Osteoporosis …, 2022 - Springer
Osteoporosis is the most common metabolic bone disease in the USA and the world. It is a
subclinical condition until complicated by fracture (s). These fractures place an enormous …

Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology

MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2021 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

[HTML][HTML] Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Collaborative Group on Hormonal Factors in Breast … - The Lancet, 2019 - Elsevier
Background Published findings on breast cancer risk associated with different types of
menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term …

Treating menopause—MHT and beyond

SR Davis, RJ Baber - Nature Reviews Endocrinology, 2022 - nature.com
Every woman who lives past midlife will experience menopause, which, by definition, is
complete cessation of ovarian function. This process might occur spontaneously (natural …

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes

R Malik, G Chauhan, M Traylor, M Sargurupremraj… - Nature …, 2018 - nature.com
Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown.
We conducted a multiancestry genome-wide-association meta-analysis in 521,612 …

Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical …

RT Chlebowski, GL Anderson, AK Aragaki… - Jama, 2020 - jamanetwork.com
Importance The influence of menopausal hormone therapy on breast cancer remains
unsettled with discordant findings from observational studies and randomized clinical trials …

Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline

WC Hembree, PT Cohen-Kettenis… - The Journal of …, 2017 - academic.oup.com
Abstract Objective To update the “Endocrine Treatment of Transsexual Persons: An
Endocrine Society Clinical Practice Guideline,” published by the Endocrine Society in 2009 …